SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040255
Filing Date
2019-11-05
Accepted
2019-11-05 14:12:56
Documents
80
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mcrb-10q_20190930.htm 10-Q 2652095
2 EX-10.1 mcrb-ex101_104.htm EX-10.1 134027
3 EX-10.3 mcrb-ex103_278.htm EX-10.3 384736
4 EX-31.1 mcrb-ex311_7.htm EX-31.1 10570
5 EX-31.2 mcrb-ex312_9.htm EX-31.2 10526
6 EX-32.1 mcrb-ex321_6.htm EX-32.1 7372
7 EX-32.2 mcrb-ex322_10.htm EX-32.2 7463
  Complete submission text file 0001564590-19-040255.txt   8607135

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT mcrb-20190930.xml EX-101.INS 1622550
9 XBRL TAXONOMY EXTENSION SCHEMA mcrb-20190930.xsd EX-101.SCH 57617
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mcrb-20190930_cal.xml EX-101.CAL 57818
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mcrb-20190930_def.xml EX-101.DEF 177361
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE mcrb-20190930_lab.xml EX-101.LAB 450166
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mcrb-20190930_pre.xml EX-101.PRE 345783
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37465 | Film No.: 191192758
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences